FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

1522801000168108: Kabiven G19% (alanine 9.6 g / 2.053 L + arginine 6.8 g / 2.053 L + aspartic acid 2 g / 2.053 L + calcium chloride dihydrate 590 mg / 2.053 L + glutamic acid 3.4 g / 2.053 L + glycine 4.7 g / 2.053 L + histidine 4.1 g / 2.053 L + isoleucine 3.4 g / 2.053 L + leucine 4.7 g / 2.053 L + lysine hydrochloride 6.8 g / 2.053 L + magnesium sulfate heptahydrate 2 g / 2.053 L + methionine 3.4 g / 2.053 L + phenylalanine 4.7 g / 2.053 L + potassium chloride 3.6 g / 2.053 L + proline 4.1 g / 2.053 L + serine 2.7 g / 2.053 L + sodium acetate trihydrate 4.9 g / 2.053 L + sodium glycerophosphate 3 g / 2.053 L + threonine 3.4 g / 2.053 L + tryptophan 1.1 g / 2.053 L + tyrosine 140 mg / 2.053 L + valine 4.4 g / 2.053 L) injection [1 x 600 mL chamber] (&) (glucose 200 g / 2.053 L) injection [1 x 1.053 L chamber] (&) (soya oil 80 g / 2.053 L) injection [1 x 400 mL chamber], 4 x 2.053 L multi-chamber bags (trade product pack)

Status: current, Defined. Date: 31-Jan 2021. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
4518921000168112 Kabiven G19% (alanine 9.6 g / 2.053 L + arginine 6.8 g / 2.053 L + aspartic acid 2 g / 2.053 L + calcium chloride dihydrate 590 mg / 2.053 L + glutamic acid 3.4 g / 2.053 L + glycine 4.7 g / 2.053 L + histidine 4.1 g / 2.053 L + isoleucine 3.4 g / 2.053 L + leucine 4.7 g / 2.053 L + lysine hydrochloride 6.8 g / 2.053 L + magnesium sulfate heptahydrate 2 g / 2.053 L + methionine 3.4 g / 2.053 L + phenylalanine 4.7 g / 2.053 L + potassium chloride 3.6 g / 2.053 L + proline 4.1 g / 2.053 L + serine 2.7 g / 2.053 L + sodium acetate trihydrate 4.9 g / 2.053 L + sodium glycerophosphate 3 g / 2.053 L + threonine 3.4 g / 2.053 L + tryptophan 1.1 g / 2.053 L + tyrosine 140 mg / 2.053 L + valine 4.4 g / 2.053 L) injection [1 x 600 mL chamber] (&) (glucose 200 g / 2.053 L) injection [1 x 1.053 L chamber] (&) (soya oil 80 g / 2.053 L) injection [1 x 400 mL chamber], 4 x 2.053 L multi-chamber bags (trade product pack) en Fully specified name Active Case sensitive Australian Medicines Terminology module
4518931000168110 Kabiven G19% (1 x Glucose chamber, 1 x Vamin 18 Novum chamber, 1 x Intralipid chamber), 4 x 2.053 L multi-chamber bags en Synonym Active Case sensitive Australian Medicines Terminology module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Kabiven G19% (1 x Glucose chamber, 1 x Vamin 18 Novum chamber, 1 x Intralipid chamber), 4 x 2.053 L multi-chamber bags Is a glucose 200 g/2.053 L injection [1.053 L chamber] (&) alanine 9.6 g/2.053 L + arginine 6.8 g/2.053 L + aspartic acid 2 g/2.053 L + glutamic acid 3.4 g/2.053 L + glycine 4.7 g/2.053 L + histidine 4.1 g/2.053 L + isoleucine 3.4 g/2.053 L + leucine 4.7 g/2.053 L + lysine hydrochloride 6.8 g/2.053 L + methionine 3.4 g/2.053 L + phenylalanine 4.7 g/2.053 L + proline 4.1 g/2.053 L + serine 2.7 g/2.053 L + threonine 3.4 g/2.053 L + tryptophan 1.1 g/2.053 L + tyrosine 140 mg/2.053 L + valine 4.4 g/2.053 L + calcium chloride dihydrate 590 mg/2.053 L + sodium glycerophosphate 3 g/2.053 L + magnesium sulfate heptahydrate 2 g/2.053 L + potassium chloride 3.6 g (potassium 48 mmol)/2.053 L + sodium acetate trihydrate 4.9 g/2.053 L injection [600 mL chamber] (&) soya oil 80 g/2.053 L injection [400 mL chamber], 4 x 2.053 L multi-chamber bags true Inferred relationship Some
Kabiven G19% (1 x Glucose chamber, 1 x Vamin 18 Novum chamber, 1 x Intralipid chamber), 4 x 2.053 L multi-chamber bags Is a trade product pack true Inferred relationship Some
Kabiven G19% (1 x Glucose chamber, 1 x Vamin 18 Novum chamber, 1 x Intralipid chamber), 4 x 2.053 L multi-chamber bags has TP Kabiven G19% true Inferred relationship Some
Kabiven G19% (1 x Glucose chamber, 1 x Vamin 18 Novum chamber, 1 x Intralipid chamber), 4 x 2.053 L multi-chamber bags has TPUU Kabiven G19% Vamin 18 Novum injection, 600 mL chamber true Inferred relationship Some 1278694562
Kabiven G19% (1 x Glucose chamber, 1 x Vamin 18 Novum chamber, 1 x Intralipid chamber), 4 x 2.053 L multi-chamber bags has TPUU Kabiven G19% Glucose 200 g/2.053 L injection, 1.053 L chamber true Inferred relationship Some 73566651
Kabiven G19% (1 x Glucose chamber, 1 x Vamin 18 Novum chamber, 1 x Intralipid chamber), 4 x 2.053 L multi-chamber bags has TPUU Kabiven G19% Intralipid 80 g/2.053 L injection, 400 mL chamber true Inferred relationship Some 1832678498
Kabiven G19% (1 x Glucose chamber, 1 x Vamin 18 Novum chamber, 1 x Intralipid chamber), 4 x 2.053 L multi-chamber bags has subpack glucose 200 g/2.053 L injection [1.053 L chamber] (&) alanine 9.6 g/2.053 L + arginine 6.8 g/2.053 L + aspartic acid 2 g/2.053 L + glutamic acid 3.4 g/2.053 L + glycine 4.7 g/2.053 L + histidine 4.1 g/2.053 L + isoleucine 3.4 g/2.053 L + leucine 4.7 g/2.053 L + lysine hydrochloride 6.8 g/2.053 L + methionine 3.4 g/2.053 L + phenylalanine 4.7 g/2.053 L + proline 4.1 g/2.053 L + serine 2.7 g/2.053 L + threonine 3.4 g/2.053 L + tryptophan 1.1 g/2.053 L + tyrosine 140 mg/2.053 L + valine 4.4 g/2.053 L + calcium chloride dihydrate 590 mg/2.053 L + sodium glycerophosphate 3 g/2.053 L + magnesium sulfate heptahydrate 2 g/2.053 L + potassium chloride 3.6 g (potassium 48 mmol)/2.053 L + sodium acetate trihydrate 4.9 g/2.053 L injection [600 mL chamber] (&) soya oil 80 g/2.053 L injection [400 mL chamber], 2.053 L multi-chamber bag true Inferred relationship Some 1241529667
Inbound Relationships Type Active Source Characteristic Refinability Group
Kabiven G19% (1 x Glucose chamber, 1 x Vamin 18 Novum chamber, 1 x Intralipid chamber), 4 x 2.053 L multi-chamber bags Is a True Kabiven G19% (1 x Glucose chamber, 1 x Vamin 18 Novum chamber, 1 x Intralipid chamber), 4 x 2.053 L multi-chamber bags Inferred relationship Some

Reference Sets

Trade product pack reference set

Back to Start